The Effects of Hormonal and Non-Hormonal Intrauterine Devices on Female Sexual Function: A Systematic Review

Overview

Journal Int J Sex Health

Publisher Routledge

Date 2024 Apr 10

PMID 38596762

Authors

Katherine Ogle

Ariel B Handy

Affiliations

Soon will be listed here.

Abstract

Objectives: The goal of this paper was to review and synthesize the extant literature exploring the impact, if any, of copper (Cu) and levonorgestrel (LNG) intrauterine devices on female sexual function.

Methods: To review the literature, Medline, PubMed, and PsychINFO, were searched for primary research articles that were available in English and measured female sexual function in Cu- and LNG-IUD users. 35 quantitative and 2 qualitative research papers met criteria for inclusion in this systematic review. The 35 quantitative articles were then rated based on the STROBE statement.

Results: The included articles indicated a positive impact of LNG-IUDs on sexual pain, and a positive-to-neutral effect of IUDs on sexual desire, however more research is warranted. This review also found IUDs to be generally non-impactful on other domains of sexual function, including arousal, lubrication, orgasm, satisfaction, and overall sexual function.

Conclusions: As this review highlights that LNG-IUDs may improve sexual pain, future research should explore this connection further. Additional RCTs should also be conducted to confirm effects on sexual function with little bias. A better understanding of the impact of both Cu- and LNG-IUDs is necessary to expand upon this field of research and uncover any other benefits or detriments from IUDs.

References

Toorzani Z, Zahraei R, Ehsanpour S, Nasiri M, Shahidi S, Soleimani B . A study on the relationship of sexual satisfaction and common contraceptive methods employed by the couples. Iran J Nurs Midwifery Res. 2011; 15(3):115-9. PMC: 3093165. View

Martin-Loeches M, Orti R, Monfort M, Ortega E, Rius J . A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices. Eur J Contracept Reprod Health Care. 2003; 8(3):129-34. View

Graham C, Sanders S, Milhausen R, McBride K . Turning on and turning off: a focus group study of the factors that affect women's sexual arousal. Arch Sex Behav. 2004; 33(6):527-38. DOI: 10.1023/B:ASEB.0000044737.62561.fd. View

Zgliczynska M, Kocaj K, Szymusik I, Dutsch-Wicherek M, Ciebiera M, Kosinska-Kaczynska K . Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review. J Clin Med. 2020; 9(7). PMC: 7408997. DOI: 10.3390/jcm9072101. View

Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P . Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol. 2012; 119(3):519-26. DOI: 10.1097/AOG.0b013e31824264c3. View

Skrzypulec V, Drosdzol A . Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system--Mirena. Coll Antropol. 2009; 32(4):1059-68. View

Jacobson J, Nasso J, Christopher Glantz J . Use of an Evidence-Based Guideline for Management of Side Effects from Long-Acting Reversible Contraceptives: A Quality Improvement Report. J Midwifery Womens Health. 2018; 64(2):225-229. DOI: 10.1111/jmwh.12925. View

Jia S, Leng J, Sun P, Lang J . Prevalence and associated factors of female sexual dysfunction in women with endometriosis. Obstet Gynecol. 2013; 121(3):601-606. DOI: 10.1097/AOG.0b013e3182835777. View

Lan S, Ling L, Jianhong Z, Xijing J, Lihui W . Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Int Med Res. 2013; 41(3):548-58. DOI: 10.1177/0300060513479865. View

10.

Hubacher D, Chen P, Park S . Side effects from the copper IUD: do they decrease over time?. Contraception. 2009; 79(5):356-62. PMC: 2702765. DOI: 10.1016/j.contraception.2008.11.012. View

11.

Baldaszti E, Wimmer-Puchinger B, Loschke K . Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. 2003; 67(2):87-91. DOI: 10.1016/s0010-7824(02)00482-1. View

12.

Fox E, Reyna A, Malcolm N, Rosmarin R, Zapata L, Frederiksen B . Client Preferences for Contraceptive Counseling: A Systematic Review. Am J Prev Med. 2018; 55(5):691-702. PMC: 6655529. DOI: 10.1016/j.amepre.2018.06.006. View

13.

Widman L, Welsh D, McNulty J, Little K . Sexual communication and contraceptive use in adolescent dating couples. J Adolesc Health. 2006; 39(6):893-9. DOI: 10.1016/j.jadohealth.2006.06.003. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

15.

Neri M, Piras B, Paoletti A, Vallerino V, Corda V, Ronchetti C . Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecol Endocrinol. 2017; 34(6):532-535. DOI: 10.1080/09513590.2017.1416465. View

16.

Oddens B . Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception. 1999; 59(5):277-86. DOI: 10.1016/s0010-7824(99)00034-7. View

17.

Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E . Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med. 2011; 9(4):1065-73. DOI: 10.1111/j.1743-6109.2011.02266.x. View

18.

Herzberg B, DRAPER K, Johnson A, Nicol G . Oral contraceptives, depression, and libido. Br Med J. 1971; 3(5773):495-500. PMC: 1800460. DOI: 10.1136/bmj.3.5773.495. View

19.

Caruso S, Cianci S, Vitale S, Fava V, Cutello S, Cianci A . Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy. Eur J Contracept Reprod Health Care. 2018; 23(1):24-31. DOI: 10.1080/13625187.2018.1433824. View

20.

Chen J, Ho S . Contraceptive status and sexual function of climacteric Chinese women. Contraception. 1999; 59(2):85-90. DOI: 10.1016/s0010-7824(99)00005-0. View